Home > Insider Trading > Filing (0001140361-22-027528)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1559053	Prothena Corp Public Ltd Co	PRTA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1564380	G. Gene Kinney	C/O Prothena Biosciences Inc 331 Oyster Point Boulevard South San Francisco CA 94080	President And Ceo	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares, Par Value $0.01 Per Share	Acquisiton	2022-07-27	376	$6.41	13,169	No	4	M	Direct
Ordinary Shares, Par Value $0.01 Per Share	Disposition	2022-07-27	376	$32.00	12,793	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Option (Right to Buy)	Disposition	2022-07-27	376	$0.00	376	$6.41

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
98,698		2023-01-29	No	4	M	Direct

Footnotes

The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.
The Reporting Person holds options that give him the right to acquire an aggregate of 2,103,398 shares at exercises prices ranging from $6.41 to $32.45, of which 1,571,938 are currently exercisable, and 531,460 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award.